Cargando…
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies
Multiple sclerosis (MS) frequently affects women of childbearing age, and an increasing number of disease-modifying therapies are available. However, a consequence of this is that women and clinicians face complex shared decisions surrounding disease-modifying therapy use in pregnancy and postpartum...
Autores principales: | Iyer, Priyanka, Dobson, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837363/ https://www.ncbi.nlm.nih.gov/pubmed/36443593 http://dx.doi.org/10.1007/s40120-022-00421-0 |
Ejemplares similares
-
Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary
por: Dobson, Ruth, et al.
Publicado: (2022) -
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
por: Mao, Zhifeng, et al.
Publicado: (2018) -
A multiple sclerosis patient-oriented multiomics analysis tells us where to go next: Commentary for: “Alterations of host-gut microbiome interactions in multiple sclerosis”
por: Yamamura, Takashi, et al.
Publicado: (2022) -
Commentary: Tackling the “silent epidemic”
por: Srinivasan, Bhaskar, et al.
Publicado: (2022) -
Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic
por: Lee, Jeong Eon, et al.
Publicado: (2011)